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Background: We investigated the mortality rates of patients with and without diabetes mellitus after acute
large-dose exposure to organophosphate insecticides. All patients without diabetes mellitus were traced to examine
the long-term risk of new-onset diabetes mellitus. Previous reports indicated that organophosphate exposure might
increase the risk of new-onset diabetes mellitus.
Methods: We analyzed the records of 118 patients referred to Chang Gung Memorial Hospital for management of
intentional organophosphate poisoning between 2000 and 2011. Patients were stratified by diabetes mellitus status.
Demographic, clinical, laboratory and mortality data were analyzed.
Results: Most patients were middle aged (53.45 ± 16.20 years) and male (65.3%) and were referred to our hospital
after a relatively short amount of time had elapsed since poisoning (median 3.0 hours). 18 (15.2%) of 118 patients
died, including 15 (13.8%) of 109 patients without diabetes mellitus and 3 (33.3%) of 9 with diabetes mellitus. There
was no significant difference in mortality between these groups (P = 0.117). In a multivariate Cox regression model,
hypotension (P = 0.000), respiratory failure (P = 0.042), coma (P = 0.023), and corrected QT interval prolongation (P =
0.002) were significant risk factors for mortality. Conversely, diabetes mellitus status was not a significant variable in
this model. At routine outpatient follow up a median of 1.25 months post exposure, random blood glucose
measurements gave no evidence of new-onset diabetes in patients without pre-existing diabetes.
Conclusions: Diabetes mellitus status might not increase mortality risk following acute large-dose exposure to
organophosphates, and the risk of new-onset diabetes mellitus also might be minimal in the short term. Larger
prospective studies with formal testing for diabetes at later times post-exposure are required.
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Intentional ingestion of organophosphate insecticide causes
many deaths each year in Taiwan [1]. Chronologically, the 3
different clinical syndromes after acute organophosphate
intoxication include (1) early acute cholinergic crisis
due to acetylcholinesterase suppression, (2) intermediate* Correspondence: m19570@adm.cgmh.org.tw
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reproduction in any medium, provided the orsyndrome (0.5–7 days) that has an unclear underlying
mechanism, and (3) delayed polyneuropathy (6–21 days)
explained by the inhibition of neuropathy target esterase.
Acute cholinergic crisis [2] includes signs and symptoms
resulting from hyperstimulation of muscarinic receptors
in the parasympathetic system (e.g., bradycardia, broncho-
spasm, bronchorrhea, hypotension, diarrhea, vomiting,
miosis, lachrymation, salivation, and urination), nicotinic
receptors in the sympathetic system (e.g., hypertension,
tachycardia, mydriasis, and sweating), nicotinic receptors
at the neuromuscular junction (e.g., muscle weakness,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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and nicotinic receptors in the central nervous system (e.g.,
confusion, agitation, coma, and respiratory failure).
We performed this study because, as demonstrated
previously, diabetes mellitus could modify drug pharma-
cokinetics by altering hepatic drug-metabolizing enzyme
activity [3,4]. In addition, Starr et al [5] found that in-
creased blood-brain barrier permeability with magnetic
resonance imaging was detected in patients with type II
diabetes or white matter hyperintensities. Increased per-
meability of the blood-brain barrier might account for
some of the cerebral effects of type II diabetes, and so
possibly also for the effect of other conditions that affect
the microvasculature (like hypertension), on the brain.
Therefore, we hypothesized that diabetic patient with or-
ganophosphates poisoning might suffer from a higher
mortality rate than patients without diabetes.
We also performed this study because several reports
have shown that organophosphates might have a special ef-
fect on the mammalian pancreas [6], especially on glucose
homeostasis and the possibility of new-onset diabetes
mellitus [7,8]. Therefore, we investigated the mortality
rates of patients with and without diabetes mellitus after
acute large-dose exposure to organophosphate insec-
ticides. In addition, all patients without diabetes mellitus
were traced to examine the short to medium term risk of
new-onset diabetes mellitus.
Methods
This retrospective observational study complied with the
Declaration of Helsinki guidelines and was approved by
the Medical Ethics Committee of Chang Gung Memorial
Hospital, a tertiary referral center located in the northern
part of Taiwan. Because this study was a retrospective re-
view of existing data, Institutional Review Board approval
was obtained, but without specific informed consent from
the patients. However, informed consent of acute organo-
phosphate poisoning risk and all treatment modalities (in-
cluding cardiopulmonary cerebral resuscitation, etc.) was
obtained from all patients at their initial admission. In
addition, all individual information was securely protected
(by delinking identifying information from the main data
set) and was available to investigators only. Furthermore,
all data were analyzed anonymously. The Institutional Re-
view Board of Chang Gung Memorial Hospital specifically
waived the need for consent. Finally, all primary data were
collected according to the Strengthening the Reporting of
Observational Studies in Epidemiology guidelines. This
policy was based on previous publications [9,10].
Patients
We analyzed the records of 118 patients with intentional
organophosphate poisoning examined at Chang Gung Me-
morial Hospital between 2000 and 2011. The diagnosis oforganophosphate poisoning was based on history of ex-
posure, clinical effects, and serum cholinesterase activity.
Serum cholinesterase activity was determined using an
enzymatic method (normal values: 7–19 U/mL) imme-
diately after the patient arrived at the hospital. The
pesticide ingested was determined by history, container
label, or product information provided by the patient. A
complete clinical profile of each patient was recorded
using a standardized form. We obtained the following
data for each patient: age, sex, blood pressure, heart
rate, type and toxicity classification of the organophos-
phate, underlying diseases, smoking habits, alcohol con-
sumption, medications, time elapsed between poisoning
and hospital arrival, duration of follow-up, clinical mani-
festations, electrocardiogram results, serum cholinesterase
level, hemogram, biochemistry, the detoxification protocol
used, and mortality.
Inclusion and exclusion criteria
All patients aged >18 years diagnosed with organophos-
phate poisoning at Chang Gung Memorial Hospital be-
tween 2000 and 2011 were eligible for inclusion in this
study. Patients were excluded if they were aged <18
years or did not have suppressed serum cholinesterase
levels despite suspicions of exposure.
Detoxification protocols
The protocols [10] used to treat patients included gastric
lavage with large amounts of normal saline, followed by
infusion of 1 g/kg activated charcoal and 250 mL of
magnesium citrate administered via a nasogastric tube.
Magnesium citrate was used to prevent constipation after
charcoal administration. Patients were also treated with
specific antidotes including atropine and oximes. Intraven-
ous atropine was administered at a starting dose of 2 mg
every 1–2 hours, and dosing was titrated to the clearing of
respiratory secretions and cessation of bronchoconstric-
tion. All patients with evidence of cholinergic toxicity
were given pralidoxime therapy (1 g every 4 hours admin-
istered intravenously).
Definition of clinical events
We classified organophosphate toxicity using the following
formal World Health Organization recommendations: class
Ia (extremely hazardous), class Ib (highly hazardous), class
II (moderately hazardous), class III (slightly hazardous), and
class U (unlikely to present acute hazard) [11]. Acute renal
failure was diagnosed if the serum creatinine level in-
creased to >1.27 mg/dL in men or 1.03 mg/dL in women.
Acute respiratory failure was defined as a condition of re-
spiratory insufficiency requiring intubation and mecha-
nical ventilation for more than 24 hours, regardless of the
fraction of inspired oxygen [12]. Hypotension was defined
as systolic blood pressure <90 mm Hg. Structural heart
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processes and related interventions [13]. Use of medications
that might be associated with corrected QT interval (QTc)
prolongation was recorded. In this regard, the antiarrhyth-
mic agents included class Ia, class Ic, and class III agents
[14]. Antimicrobials included macrolides/ketolides, certain
fluoroquinolones, certain antimalarials, pentamidine, and
azole antifungals [15]. Antipsychotics and antidepressants
included (1) typical antipsychotics such as chlorpromazine,
pimozide, thioridazine, perphenazine, trifluoperazine, halo-
peridol, and droperidol; (2) atypical antipsychotics such as
clozapine, quetiapine, risperidone, sultopride, ziprasidone,
and loxapine; (3) tricyclic antidepressants such as amitrip-
tyline, amoxapine, clomipramine, desipramine, citalopram,
doxepin, imipramine, nortriptyline, and trimipramine; and
(4) other antidepressants such as fluoxetine, sertraline, and
venlafaxine [16]. New-onset diabetes mellitus was defined
as casual plasma glucose ≥200 mg/dL [17,18] that occurred
in patients without pre-existing diabetes mellitus.
Statistical analysis
Continuous variables are expressed as the mean and stand-
ard deviation and categorical variables as the number with
percentage in brackets. All data were tested for normality
of distribution and equality of standard deviations before
analysis. For comparisons between patient groups, we used
Student's t-test for quantitative variables and chi-square or
Fisher's exact test for categorical variables. Mortality data
were compared using the Kaplan-Meier method and sig-
nificance was tested using a log rank test. An initial univari-
ate Cox regression analysis was performed to compare the
frequency of possible risk factors associated with mortality.
To control for possible confounding factors, a multivariate
Cox regression analysis (backward stepwise approach) was
performed to analyze factors that were significant in univar-
iate models (P < 0.05) and met the assumptions of a propor-
tional hazards model. Results that rejected the null
hypothesis with 95% confidence were considered signifi-
cant. All analyses were performed using SPSS, version 12.0
for Windows (SPSS Inc., Chicago, Illinois, USA).
Results
Table 1 shows the baseline characteristics of the 118 pa-
tients with organophosphate poisoning overall and by dia-
betes mellitus status. Of the 118 patients, 109 were in the
non–diabetes mellitus group and 9 were in the diabetes
mellitus group. Most of the patients were middle aged
(53.45 ± 16.20 years) and men (65.3%) and were referred to
our hospital after a relatively short amount of time had
elapsed since poisoning (median 3.0 hours). Notably, nearly
half of the patients had a history of a mental disorder
(43.2%) and were undergoing long-term treatment with
antipsychotic and antidepressant medications (25.4%). After
analysis, we found that patients with diabetes mellitus wereolder than patients without diabetes mellitus (52.32 ± 16.04
versus 67.11 ± 11.84 years; P = 0.008). Otherwise, there were
no significant differences in baseline variables between the
groups (P > 0.05).
After ingestion, the patients developed acute choliner-
gic crisis (Table 2) that included respiratory failure
(51.7%), emesis (35.6%), diarrhea (29.7%), hypotension
(22.9%), coma (19.5%), acute renal failure (9.3%), and
seizure (8.5%), among other conditions. Intermediate
syndrome and delayed polyneuropathy were also present
in 8.5% and 2.5% of patients, respectively. Nevertheless,
there were no significant differences in clinical variables
between the groups (P > 0.05). Laboratory analysis re-
vealed suppressed initial and nadir serum cholinesterase
levels (3.29 ± 3.53 U/mL and 2.79 ± 3.06 U/mL, respect-
ively) (Table 3). There were no significant differences in
laboratory variables between the groups (P > 0.05).
As shown in Table 4, most patients were aggressively
treated with gastric lavage with large amounts of normal
saline, followed by an infusion of 1 g/kg activated char-
coal and 250 mL of magnesium citrate. In addition,
nearly all patients were administered systemic atropine
and pralidoxime injections. There was no difference in
treatment modality between the groups except a slightly
lower use of atropine in the diabetes mellitus group
compared with the non-diabetes mellitus group (88.9%
versus 99.1%; P = 0.023).
The median follow-up duration was 1.25 months. 18
(15.3) of 118 patients died, including 15 (13.8%) of 109
patients without diabetes mellitus and 3 (33.3%) of 9 pa-
tients with diabetes mellitus. There was no significant
difference in mortality between the groups (P = 0.117)
(Table 4). Similarly, there was no difference in the cause
of mortality between patients with and without diabetes
mellitus (P = 0.333).
A multivariate Cox regression model demonstrated
that hypotension, respiratory failure, coma, and QTc
prolongation were significant risk factors for mortality
(Table 5). Notably, diabetes mellitus status was not a sig-
nificant variable according to this model (P = 0.117).
Regarding the possibility of new-onset diabetes mellitus,
all 94 of 109 non–diabetes mellitus patients were success-
fully traced at least 1 time between 2000 and 2012 except 15
patients died during admission. The random blood sugar
level was checked during follow-up. At routine outpatient
follow up a median of 1.25 months post exposure, random
blood glucose measurements gave no evidence of new-onset
diabetes in patients without pre-existing diabetes. The other
6 of 9 diabetes mellitus patients were successfully traced as
well except 3 patients died during admission (Table 6).
Discussion
This study is of particular interest because it showed that
diabetes mellitus status might not increase mortality risk
Table 1 Baseline characteristics of patients with organophosphate poisoning, stratified according to diabetes mellitus
status (N = 118)
Variable Total (N = 118) Non-diabetes mellitus (N = 109) Diabetes mellitus (N = 9) P
Age, years (mean ± SD) 53.45 ± 16.20 52.32 ± 16.04 67.11 ± 11.84 0.008**
Male, n (%) 77 (65.3) 73 (67.0) 4 (44.4) 0.173
Organophosphate type, n (%): 0.082
Chlorpyrifos 48 (40.7) 44 (40.4) 4 (44.4)
Profenofos 16 (13.6) 16 (14.7) 0 (0.0)
Methamidophos 14 (11.9) 14 (12.8) 0 (0.0)
Mevinphos 10 (8.5) 9 (8.3) 1 (11.1)
Dimethoate 9 (7.6) 8 (7.3) 1 (11.1)
Malathion 6 (5.1) 5 (4.6) 1 (11.1)
Parathion 4 (3.4) 4 (3.7) 0 (0.0)
Acephate 3 (2.5) 2 (1.8) 1 (11.1)
Trichlorfon 3 (2.5) 3 (2.8) 0 (0.0)
Terbufos 2 (1.7) 2 (1.8) 0 (0.0)
Dichlorvos 1 (0.8) 1 (0.9) 0 (0.0)
Fenamiphos 1 (0.8) 1 (0.9) 0 (0.0)
Phorate 1 (0.8) 0 (0.0) 1 (11.1)
Organophosphate toxicity, n (%): 0.206
Ia, extremely hazardous 17 (14.4) 15 (13.8) 2 (22.2)
Ib, highly hazardous 16 (13.6) 16 (14.7) 0 (0.0)
II, moderately hazardous 76 (64.4) 71 (65.1) 5 (55.6)
III, slightly hazardous 9 (7.6) 7 (6.4) 2 (22.2)
U, unlikely to present acute hazard 0 (0) 0 (0) 0 (0)
Hypertension, n (%) 21 (17.8) 18 (16.5) 3 (33.3) 0.199
Old stroke, n (%) 10 (8.5) 8 (7.3) 2 (22.2) 0.123
Coronary artery disease, n (%) 3 (2.5) 3 (2.8) 0 (0.0) 0.614
Structural heart disease, n (%) 11 (9.3) 10 (9.2) 1 (11.1) 0.848
Chronic obstructive pulmonary disease, n (%) 9 (7.6) 8 (7.3) 1 (11.1) 0.682
Malignancy, n (%) 3 (2.5) 3 (2.8) 0 (0.0) 0.614
Mental disorder, n (%) 51 (43.2) 46 (42.2) 5 (55.6) 0.437
Smoking habit, n (%) 52 (44.1) 50 (45.9) 2 (22.2) 0.170
Alcohol consumption, n (%) 49 (41.5) 47 (43.1) 2 (22.2) 0.221
Use of medications that might be associated with QTc
7prolongation, n (%):
Antiarrhythmic agents 20 (16.9) 17 (15.6) 3 (33.3) 0.173
Antipsychotics and antidepressants 30 (25.4) 27 (24.8) 3 (33.3) 0.571
Antimicrobials 10 (8.5) 9 (8.3) 1 (11.1) 0.768
QTc, corrected QT interval.
Note: **P < 0.01.
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(P = 0.117) (Table 4). Furthermore, the risk of new-onset
diabetes mellitus after acute intoxication within the short
term also might be minimal.
The relationship between organophosphate exposure
and subsequent new-onset diabetes mellitus remains un-
clear. A previous animal study [19] found that dimethoateat subchronic oral doses had the propensity to impair glu-
cose homeostasis and induce significant pancreatic dam-
age, and also provide an account of the associated
oxidative damage to pancreatic tissue in adult rats. Add-
itionally [20], the toxicity of diazinon and its metabolites
increases in diabetic rats. Slotkin [21] also reported that
organophosphate exposure in neonatal rats during a
Table 2 Clinical manifestations of patients with organophosphate poisoning, stratified according to diabetes mellitus
status (N = 118)
Variable Total (N = 118) Non–diabetes mellitus (N = 109) Diabetes mellitus (N = 9) P
1. Cholinergic crisis
Cardiovascular system:
Systolic BP, mm Hg (mean ± SD) 116.81 ± 23.21 117.46 ± 22.98 108.89 ± 26.00 0.289
Diastolic BP, mm Hg (mean ± SD) 79.68 ± 18.24 80.30 ± 17.88 72.11 ± 21.92 0.197
Heart rate, beats/minute (mean ± SD) 102.04 ± 26.72 103.26 ± 27.75 91.43 ± 11.10 0.270
Hypotension, n (%) 27 (22.9) 24 (22.0) 3 (33.3) 0.437
Gastrointestinal system, n (%):
Diarrhea 35 (29.7) 35 (32.1) 0 (0.0) 0.053
Emesis 42 (35.6) 40 (36.7) 2 (22.2) 0.383
Respiratory system, n (%):
Shortness of breath 81 (68.6) 75 (68.8) 6 (66.7) 0.894
Bronchorrhea 72 (61.0) 66 (60.6) 6 (66.7) 0.718
Bronchospasm 67 (56.8) 61 (56.0) 6 (66.7) 0.533
Respiratory failure 61 (51.7) 55 (50.5) 6 (66.7) 0.350
Genitourinary system n (%):
Acute renal failure 11 (9.3) 10 (9.2) 1 (11.1) 0.848
Central nervous system n (%):
Seizure 10 (8.5) 8 (7.3) 2 (22.2) 0.123
Coma 23 (19.5) 21 (19.3) 2 (22.2) 0.830
2. Intermediate syndrome, n (%) 10 (8.5) 10 (9.2) 0 (0.0) 0.342
3. Delayed polyneuropathy, n (%) 3 (2.5) 3 (2.8) 0 (0.0) 0.614
SD, standard deviation; BP, blood pressure.
Table 3 Laboratory findings of patients with organophosphate poisoning, stratified according to diabetes mellitus
status (N = 118)
Variable (mean ± SD) Total (N = 118) Non–diabetes mellitus (N = 109) Diabetes mellitus (N = 9) P
Hemoglobin, g/dL 14.33 ± 1.91 14.37 ± 1.95 13.81 ± 1.30 0.428
Blood urea nitrogen, mg/dL 16.74 ± 16.45 16.34 ± 16.71 25.20 ± 4.53 0.463
Creatinine, mg/dL 1.06 ± 0.72 1.05 ± 0.74 1.14 ± 0.47 0.741
Sodium, mEq/L 140.97 ± 3.68 141.04 ± 3.72 140.13 ± 3.40 0.502
Potassium, mEq/L 3.50 ± 0.54 3.48 ± 0.51 3.75 ± 0.76 0.167
Cholinesterase (initial), U/mL 3.29 ± 3.53 3.18 ± 3.24 4.67 ± 6.31 0.254
Cholinesterase (lowest), U/mL 2.79 ± 3.06 2.65 ± 2.65 4.65 ± 6.28 0.400
C-reactive protein, mg/dL 8.18 ± 18.67 8.13 ± 19.31 8.77 ± 15.65 0.616
Amylase, U/L 195.98 ± 167.47 197.62 ± 162.72 176.18 ± 187.21 0.910
Lipase, U/L 113.50 ± 115.10 113.89 ± 117.96 108.74 ± 84.24 0.365
CK-MB, ng/mL 17.98 ± 61.03 17.56 ± 64.77 23.07 ± 48.23 0.691
Troponin-I, ng/mL 0.07 ± 0.13 0.08 ± 0.14 0.05 ± 0.12 0.618
QT interval, ms 369.07 ± 57.59 366.61 ± 58.56 390.57 ± 46.20 0.301
QTc interval, ms 443.18 ± 52.71 440.21 ± 52.96 479.29 ± 53.52 0.236
SD, standard deviation; CK-MB, creatinine kinase MB; QTc, corrected QT interval.
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Table 4 Detoxification protocol and treatment outcome for patients with organophosphate poisoning, stratified
according to diabetes mellitus status (N = 118)
Variable Total (N = 118) Non–diabetes mellitus (N = 109) Diabetes mellitus (N = 9) P
Gastric lavage, n (%) 95 (80.5) 89 (81.7) 6 (66.7) 0.275
Active charcoal and magnesium citrate, n (%) 88 (74.6) 83 (76.1) 5 (55.6) 0.173
Atropine, n (%) 116 (98.3) 108 (99.1) 8 (88.9) 0.023*
Pralidoxime, n (%) 115 (97.5) 107 (98.2) 8 (88.9) 0.089
Time from poisoning to hospital, hours (median, IQR) 3.0 (2.0, 5.0) 3.0 (2.0, 5.0) 3.5 (2.0, 9.0) 0.893
Duration of follow-up, months (median, IQR) 1.25 (0.40, 9.06) 1.23 (0.43, 8.63) 2.27 (0.25, 15.67) 0.219
Mortality, n (%) 18 (15.3) 15 (13.8) 3 (33.3) 0.117
Cause of death, n (%) 0.333
Cardiogenic 10 (8.5) 8 (7.3) 2 (22.2)
Respiratory failure 6 (5.1) 5 (4.6) 1 (11.1)
Sepsis 2 (1.7) 2 (1.8) 0 (0.0)
IQR, interquartile range.
Note: *P < 0.05.
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hepatic adenylyl cyclase/cyclic AMP signaling, culminat-
ing in hyperresponsiveness to gluconeogenic stimuli. Con-
sequently, the rats developed a metabolic dysfunction
resembling prediabetes. Finally, it has been shown [22]
that low-dose administration of chlorpyrifos in rats re-
sulted in decreased activity of paraoxonase in serum,
which was accompanied by an increased level of lipid per-
oxides. This oxidative stress might explain the further de-
velopment of arteriosclerosis, hypercholesterolemia, and
diabetes mellitus in people exposed to organophosphate
compounds.
Shobha et al [23] reported transient glycosuria in 69%
of patients after organophosphate poisoning. However,
none of the patients had new-onset diabetes mellitus
and the pre–hospital discharge blood sugars were in the
normal range. Conversely [24-26], organophosphate in-
toxication presenting as diabetic ketoacidosis has been
repeatedly reported in the pediatric population. Using
data from the Agricultural Health Study, Saldana et al
[7] found that activities involving exposure to agricul-
tural pesticides during the first trimester of pregnancy
might increase the risk of gestational diabetes mellitus.
In another study using Agricultural Health Study dataTable 5 Univariate and multivariate Cox regression analysis f
Variable Univariate analysis OR (95% CI) P
Hypotension 21.596 (6.237–74.780) 0.
Respiratory failure 8.504 (1.955–36.997) 0.
Coma 10.317 (3.857–27.595) 0.
QTc prolongation 9.974 (2.885–34.478) 0.
Diabetes mellitus 2.634 (0.762–9.103) 0.
QTc, corrected QT interval.
Note: *P < 0.05, **P < 0.01, ***P < 0.001.[8], it was proven that long-term exposure to dichlorvos
and trichlorfon among licensed pesticide applicators
could increase the risk of incident diabetes mellitus. Fi-
nally, a systematic review in 2010 [27] revealed that or-
ganophosphates impair the enzymatic pathways involved
in the metabolism of carbohydrates within cytoplasm,
mitochondria, and peroxisomes. Organophosphates exert
this effect by inhibiting acetyl cholinesterase or affect-
ing target organs (such as the pancreas, liver, muscles,
and brain) directly. Furthermore, organophosphates
also induce cellular oxidative stress by affecting mito-
chondrial function and therefore disrupt the neuronal
and hormonal status of the body. Taken together, both
central (pancreas) and peripheral glucose regulatory
mechanisms could be impaired after organophosphate
exposure [27].
In this study, it was found that the diabetic cohort had
lesser load of poisoining as evidenced by the levels of
initial cholinesterase (4.67 U/mL versus 3.18 U/mL; P =
0.254) and needed less atropine (99.1% versus 88.9%;
P = 0.023). It is also possible that the mortality rates
were affected by the less severe load in patient with dia-
betes mellitus. Nevertheless, the incidence of significant risk
factors for mortality such as hypotension (22.0% versusor mortality (N = 118)
Multivariate analysis OR (95% CI) P
000*** 10.930 (2.961–40.345) 0.000***
004** 4.867 (1.062–22.301) 0.042*
000*** 3.482 (1.184–10.238) 0.023*
000*** 7.459 (2.053–27.099) 0.002**
126
Table 6 Random blood glucose test after acute large-dose exposure to organophosphates in patients with and without
diabetes mellitus (N = 118)
Variable (mean ± SD) Total (N = 118) Non–diabetes mellitus (N = 109) Diabetes mellitus (N = 9) P
Sugar, mg/dL (during hospitalization) 164.3 ± 83.1 144.7 ± 43.6 279.8 ± 10151.0 0.000***
Sugar, mg/dL (after discharge) 142.2 ± 53.7 124.9 ± 22.5 244.0 ± 71.0 0.000***
SD, standard deviation.
Note: ***P < 0.001.
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(19.3% versus 22.2%) were higher in patient with diabetes
mellitus. Small patient population may be the reason of
non-significance in mortality rate between patient with and
without diabetes mellitus.
A multivariate Cox regression analysis (Table 5) con-
firmed that hypotension, respiratory failure, coma, and QTc
prolongation were significant risk factors for mortality after
organophosphate poisoning. The associations between both
hypotension [28] and coma with mortality were not sur-
prising because both are important vital signs, irrespective
of the cause of disease. Similarly, it was not surprising
to find an association between respiratory failure and
mortality because respiratory failure is a prominent fea-
ture of acute organophosphate poisoning with an early
central apnea followed by later pulmonary effects [29].
Animal studies have also suggested that organophosphate-
induced respiratory failure results from local effects of
organophosphates acting on brainstem circuits under-
lying respiratory rhythmogenesis, and on lung tissues
underlying pulmonary secretory, airway, and vascular
function [29]. Finally, Chuang et al [30] confirmed that
patients with QTc prolongation had a higher mortality
rate and a higher incidence of respiratory failure than
patients without QTc prolongation.
The retrospective nature, small patient population, short
follow-up duration, and inadequate definition of new-
onset diabetes mellitus limit the certainty of our conclu-
sions. Therefore, a prospective study with larger patient
numbers, longer follow up, and strict assessment of new-
onset diabetes mellitus (such as glycated hemoglobin or
oral glucose tolerance test) are required to confirm our
conclusion.
Conclusions
Diabetes mellitus status might not increase mortality risk
following acute large-dose exposure to organophosphates,
and the risk of new-onset diabetes mellitus also might be
minimal in the short term. Larger prospective studies with
formal testing for diabetes at later times post-exposure are
required.
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